Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000432703 | SCV000510728 | likely benign | not provided | 2016-07-13 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Genetic Services Laboratory, |
RCV000503682 | SCV000593102 | likely benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001257053 | SCV000655553 | benign | Congenital myasthenic syndrome 15 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000432703 | SCV001894272 | benign | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28820871) |
Ce |
RCV000432703 | SCV002544296 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ALG14: BP4, BS1, BS2 |
Fulgent Genetics, |
RCV002480277 | SCV002799989 | likely benign | Congenital myasthenic syndrome 15; Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies; Myopathy, epilepsy, and progressive cerebral atrophy | 2021-09-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001257053 | SCV004049509 | likely benign | Congenital myasthenic syndrome 15 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003343806 | SCV004049510 | likely benign | Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003343807 | SCV004049511 | likely benign | Myopathy, epilepsy, and progressive cerebral atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003932543 | SCV004748877 | benign | ALG14-related condition | 2020-04-27 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |